Sign in

NCT07140094Recruiting

Long-Covid-19 Alleviation Through Learning Mindfulness Study

Long-Covid-19 Alleviation Through Learning Mindfulness Study (LONG-CALM)

Source: ClinicalTrials.gov · Last updated 31 Aug 2026

Brief summary (registry, in English)

This research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID. Mindfulness is defined as paying attention to the present moment with non-judgment and acceptance. Here the investigators are studying whether a mindfulness intervention can help reduce stress, reduce Long COVID symptoms, and improve quality of life among people living with Long COVID. The mindfulness intervention is a series of recorded mindfulness sessions, which were created by the study team. People who decide to take part will be randomly assigned to receive the study mindfulness intervention immediately after joining the study or to receive the study mindfulness intervention 8 weeks after joining the study. All participants will continue their usual medical care. Participants will complete online surveys to measure symptoms over time. The study will last 6 months.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
400 (estimated)
First submitted
21 Aug 2025
Start date
21 May 2024
Primary completion date
21 May 2027
Lead sponsor
Columbia University
NCT number
NCT07140094

What you commit to

  • Study type: Interventional
  • Planned participants: 400
  • From 21 May 2024 to the primary completion date, 21 May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Participating in another clinical trial of an intervention for PASC symptoms
  • Engaged in a structured MBI

Who the study is looking for

  • Age \> or = 18
  • Willing and able to provide informed consent
  • Access to the internet
  • Self-reported history of SARS-CoV-2 infection
  • Current symptoms attributed to PASC by participant or by participant's medical provider; ongoing symptoms that persisted \>= 12 weeks after Covid-19 illness

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Columbia University
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.